BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 01, 2010
 |  BC Week In Review  |  Company News  |  Deals

Allist Pharmaceuticals, Prometic deal

Allist received exclusive rights to develop and commercialize ProMetic's PBI-1402 to treat chemotherapy-induced anemia (CIA) and cancer-related anemia and PBI-4419 to treat fibrotic diseases in China. Allist...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >